E William St Clair

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Venues

Nature medicine

RMD open

This page only lists publications with an associated author ORCID identifier.

Publications

E William St Clair, Alan N Baer, Wan-Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K Tarrant, Athena Papas, Valerie Devauchelle-Pensec, Liangwei Wang, Wenjing Xu, Tuyet-Hang Pham, Keith Sikora, William A Rees, Ilias Alevizos
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial. Nature medicine 30 (6) (2024)
E William St Clair, Alan N Baer, Wan-Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K Tarrant, Athena Papas, Valerie Devauchelle-Pensec, Liangwei Wang, Wenjing Xu, Tuyet-Hang Pham, Keith Sikora, William A Rees, Ilias Alevizos
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial. Nature medicine (2024)
E William St Clair, Alan N Baer, Wan-Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K Tarrant, Athena Papas, Valerie Devauchelle-Pensec, Liangwei Wang, Wenjing Xu, Tuyet-Hang Pham, Keith Sikora, William A Rees, Ilias Alevizos
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial. Nature medicine 30 (6) (2024)
E William St Clair, Alan N Baer, Wan-Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K Tarrant, Athena Papas, Valerie Devauchelle-Pensec, Liangwei Wang, Wenjing Xu, Tuyet-Hang Pham, Keith Sikora, William A Rees, Ilias Alevizos
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial. Nature medicine 30 (6) (2024)
E William St Clair, Alan N Baer, Wan-Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K Tarrant, Athena Papas, Valerie Devauchelle-Pensec, Liangwei Wang, Wenjing Xu, Tuyet-Hang Pham, Keith Sikora, William A Rees, Ilias Alevizos
CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial. Nature medicine 30 (6) (2024)
Marta Casal Moura, Zuoming Deng, Stephen R Brooks, Wei Tew, Fernando C Fervenza, Cees G M Kallenberg, Carol A Langford, Peter A Merkel, Paul A Monach, Philip Seo, Robert F Spiera, E William St Clair, John H Stone, Marco Prunotto, Peter C Grayson, Ulrich Specks
Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism. RMD open 9 (1) (2023)
Alan Kivitz, Liangwei Wang, Ilias Alevizos, Michele Gunsior, Judith Falloon, Gabor Illei, E William St Clair
The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis. RMD open 9 (3) (2023)

E William St Clair.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

E William St Clair